Shenzhen New Industries Biomedical Engineering Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 4/6
Shenzhen New Industries Biomedical Engineering has been growing earnings at an average annual rate of 19.4%, while the Medical Equipment industry saw earnings growing at 6.4% annually. Revenues have been growing at an average rate of 19.5% per year. Shenzhen New Industries Biomedical Engineering's return on equity is 22.8%, and it has net margins of 41.7%.
Wichtige Informationen
19.4%
Wachstumsrate der Gewinne
17.5%
EPS-Wachstumsrate
| Medical Equipment Wachstum der Industrie | 16.0% |
| Wachstumsrate der Einnahmen | 19.5% |
| Eigenkapitalrendite | 22.8% |
| Netto-Marge | 41.7% |
| Letzte Ertragsaktualisierung | 30 Sep 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Should You Be Adding Shenzhen New Industries Biomedical Engineering (SZSE:300832) To Your Watchlist Today?
Oct 14
Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Aug 25A Look At The Intrinsic Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)
Jul 01Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today
Apr 09The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence
Mar 18Estimating The Fair Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)
Mar 01Aufschlüsselung der Einnahmen und Ausgaben
Wie Shenzhen New Industries Biomedical Engineering Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Sep 24 | 4,436 | 1,851 | 795 | 422 |
| 30 Jun 24 | 4,275 | 1,807 | 761 | 398 |
| 31 Mar 24 | 4,075 | 1,725 | 794 | 384 |
| 31 Dec 23 | 3,930 | 1,654 | 747 | 366 |
| 30 Sep 23 | 3,658 | 1,590 | 608 | 366 |
| 30 Jun 23 | 3,495 | 1,508 | 582 | 357 |
| 31 Mar 23 | 3,180 | 1,375 | 490 | 342 |
| 01 Jan 23 | 3,047 | 1,328 | 478 | 318 |
| 30 Sep 22 | 2,948 | 1,233 | 507 | 296 |
| 30 Jun 22 | 2,737 | 1,115 | 495 | 262 |
| 31 Mar 22 | 2,756 | 1,114 | 505 | 233 |
| 01 Jan 22 | 2,545 | 974 | 530 | 215 |
| 30 Sep 21 | 2,518 | 906 | 626 | 180 |
| 30 Jun 21 | 2,451 | 892 | 634 | 155 |
| 31 Mar 21 | 2,439 | 997 | 603 | 163 |
| 31 Dec 20 | 2,195 | 939 | 515 | 151 |
| 30 Sep 20 | 2,065 | 911 | 484 | 147 |
| 30 Jun 20 | 1,911 | 910 | 427 | 143 |
| 31 Mar 20 | 1,655 | 745 | 397 | 120 |
| 31 Dec 19 | 1,682 | 773 | 393 | 119 |
| 31 Dec 18 | 1,384 | 694 | 306 | 84 |
| 31 Dec 17 | 1,141 | 538 | 243 | 56 |
| 31 Dec 16 | 923 | 452 | 246 | 0 |
| 30 Sep 16 | 867 | 380 | 276 | 0 |
| 30 Jun 16 | 811 | 307 | 306 | 0 |
| 31 Mar 16 | 771 | 278 | 299 | 0 |
| 31 Dec 15 | 732 | 249 | 292 | 0 |
| 30 Sep 15 | 677 | 264 | 226 | 0 |
| 30 Jun 15 | 623 | 279 | 160 | 0 |
| 31 Mar 15 | 584 | 266 | 149 | 0 |
| 31 Dec 14 | 545 | 253 | 138 | 0 |
| 30 Sep 14 | 506 | 224 | 134 | 0 |
| 30 Jun 14 | 467 | 194 | 130 | 0 |
| 31 Mar 14 | 423 | 168 | 120 | 0 |
| 31 Dec 13 | 378 | 141 | 110 | 0 |
Qualität der Erträge: 300832 has high quality earnings.
Wachsende Gewinnspanne: 300832's current net profit margins (41.7%) are lower than last year (43.5%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 300832's earnings have grown by 19.4% per year over the past 5 years.
Beschleunigtes Wachstum: 300832's earnings growth over the past year (16.4%) is below its 5-year average (19.4% per year).
Erträge im Vergleich zur Industrie: 300832 earnings growth over the past year (16.4%) exceeded the Medical Equipment industry -8.8%.
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 300832's Return on Equity (22.8%) is considered high.